A quantitative and relative increase in intestinal bacteroides in allergic infants in rural Japan.

Recent studies have suggested that intestinal microbiota play a substantial role in the development of allergic diseases during infancy. We analyzed fecal microbiota in 18 Japanese infants with or without allergy at 6 months and 2 years of age using a cell culture technique. Allergy determination was based on doctor-diagnosed allergic diseases and skin prick tests. There were no differences between 9 allergic and 9 non-allergic infants at 6 months of age in the frequencies or counts of 13 genera and yeast-like organisms. Bifidobacterium was dominant in all infants irrespective of allergy status. At 2 years of age, 8 infants were non-allergic and 10 infants were allergic. Allergic infants at 2 years of age had higher counts of Bacteroides and higher ratios of Bacteroides to Bifidobacterium than non-allergic infants. Despite the small population size used in this study, the results support a significant role of Bacteroides in the pathogenesis of allergy during infancy.

[1]  D. Strachan,et al.  Gut microbiota and development of atopic eczema in 3 European birth cohorts. , 2007, The Journal of allergy and clinical immunology.

[2]  Y. Kohno,et al.  Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[3]  K. Julge,et al.  Intestinal microbiota and immunoglobulin E responses in 5‐year‐old Estonian children , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[5]  Y. Narisawa,et al.  Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. , 2003, The Journal of allergy and clinical immunology.

[6]  Y. Koga,et al.  An oral introduction of intestinal bacteria prevents the development of a long‐term Th2‐skewed immunological memory induced by neonatal antibiotic treatment in mice , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  S. Salminen,et al.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? , 2002, Gut.

[8]  I. Brook.  Clinical review: Bacteremia caused by anaerobic bacteria in children , 2002, Critical care.

[9]  S. Salminen,et al.  Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. , 2001, FEMS immunology and medical microbiology.

[10]  K. Julge,et al.  Allergy development and the intestinal microflora during the first year of life. , 2001, The Journal of allergy and clinical immunology.

[11]  P. Toivanen,et al.  Influence of Major Histocompatibility Complex on Bacterial Composition of Fecal Flora , 2001, Infection and Immunity.

[12]  J. Cebra,et al.  Influences of microbiota on intestinal immune system development. , 1999, The American journal of clinical nutrition.

[13]  P. Naaber,et al.  The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  H. Nelson,et al.  Immediate skin test reactivity to Food and Drug Administration-approved standardized extracts. , 1990, The Journal of allergy and clinical immunology.

[15]  Y. Benno,et al.  Comparison of the Fecal Microflora in Rural Japanese and Urban Canadians , 1986, Microbiology and immunology.

[16]  A. Onderdonk,et al.  Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora , 1981, Infection and immunity.

[17]  M. Sakamoto,et al.  Fluctuation of fecal microbiota in individuals with Japanese cedar pollinosis during the pollen season and influence of probiotic intake. , 2007, Journal of investigational allergology & clinical immunology.

[18]  M. Nambu,et al.  Intestinal microflora at 4 months of age and the development of allergy , 2004 .

[19]  S. Taniuchi,et al.  [Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis]. , 2003, Arerugi = [Allergy].

[20]  S. Salminen,et al.  Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. , 2001, The Journal of allergy and clinical immunology.